<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B01F1085-ECA5-47BF-B990-4A4B16DAEF8B"><gtr:id>B01F1085-ECA5-47BF-B990-4A4B16DAEF8B</gtr:id><gtr:name>Inova Technology</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Human Genetics</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B01F1085-ECA5-47BF-B990-4A4B16DAEF8B"><gtr:id>B01F1085-ECA5-47BF-B990-4A4B16DAEF8B</gtr:id><gtr:name>Inova Technology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9A895E6F-82EB-4F84-A000-64CF582886F5"><gtr:id>9A895E6F-82EB-4F84-A000-64CF582886F5</gtr:id><gtr:name>BD Biosciences</gtr:name><gtr:address><gtr:line1>BD Biosciences</gtr:line1><gtr:line2>Bioimaging Systems</gtr:line2><gtr:line3>21 Between Towns</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX4 3LY</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4DF1BF77-EEC5-41C6-A6E0-ACED9578E12C"><gtr:id>4DF1BF77-EEC5-41C6-A6E0-ACED9578E12C</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Dimmick</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F31D4947-708C-4E72-8A87-651B54C39C8B"><gtr:id>F31D4947-708C-4E72-8A87-651B54C39C8B</gtr:id><gtr:firstName>Majlinda</gtr:firstName><gtr:surname>Lako</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/50CAF208-AA43-44B5-9776-D6D6B84CA173"><gtr:id>50CAF208-AA43-44B5-9776-D6D6B84CA173</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:otherNames>Mary</gtr:otherNames><gtr:surname>Arthur</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E041E319-E561-4A17-916C-DCF2EC196DD9"><gtr:id>E041E319-E561-4A17-916C-DCF2EC196DD9</gtr:id><gtr:firstName>Lyle</gtr:firstName><gtr:surname>Armstrong</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/73122BEB-DF6D-4E66-8944-FC87EF1DCD82"><gtr:id>73122BEB-DF6D-4E66-8944-FC87EF1DCD82</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Elliott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1B12D021-9C04-4403-96BE-EF6BD4F7227E"><gtr:id>1B12D021-9C04-4403-96BE-EF6BD4F7227E</gtr:id><gtr:firstName>CG</gtr:firstName><gtr:surname>Miles</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1037EE86-C449-41B2-889C-377AC348472A"><gtr:id>1037EE86-C449-41B2-889C-377AC348472A</gtr:id><gtr:firstName>Karim</gtr:firstName><gtr:surname>Nayernia</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FE012841%2F1"><gtr:id>9670E469-AB4D-4396-9697-5612A14CD715</gtr:id><gtr:title>A state of the art multiparametric flow cytometry analysis system for multidisciplinary stem cell research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E012841/1</gtr:grantReference><gtr:abstractText>Stem cells are capable of essentially extensive growth whilst retaining the ability to differentiate into most of the cell types found in the adult but unless we can find ways to grow them in large numbers while directing them to differentiate into therapeutically useful cells much of this potential will not be realised. A major obstacle impacting the derivation of differentiated cell types from stem cells is that current in vitro differentiation strategies often only produced the desired cells in small numbers. This means they must be separated from the other cell types present and one of the best techniques we have for doing this is flow cytometry. This technology relies upon the binding of fluorescent labelled antibodies to the surfaces of our desired cells such that when they pass through the flow cytometer they can be separated from the others and retain their viability. If appropriate antibodies are available, up to 12 different colours can be analysed at any one time using the instrumentation detailed in this proposal and this offers us an unparalleled advantage in cell identification and separation. There are a number of active research groups at the Institute of Human Genetics investigating a range of differentiation protocols designed to produce useful cells from a range of stem cells and flow cytometry instrumentation is not only indispensable to this work but is also subject to very heavy demand. In view of this, a successful outcome of this proposal would greatly enhance our ability to develop useful techniques for stem cell differentiation that will ultimately benefit medical science in general.</gtr:abstractText><gtr:technicalSummary>Stem cells, both embryonic and adult offer great promise for the development of therapeutic applications but for both of these stem cell types, separation of specific cells will be required. In the case of embryonic stem cells there is a need for culture strategies that can direct their differentiation towards therapeutically useful cells but currently available techniques produce heterogeneous mixtures from which we need to separate the desired cells. Adult stem cells exist in heterogeneous microenvironments or niches and again are often present in only very small numbers underlining the requirement for advanced separation technologies. Fluorescence activated cell sorting (FACS) is the most versatile method for separating such small numbers, provided that specific antibodies are available for the surface proteins of a specific cell type. A great advantage of FACS is that multiple antibodies labelled with different fluorochromes may be used in a single cell sample thereby increasing the total data available from a single experiment. Such multiparametric flow cytometry is cost effective in terms of antisera consumption and permits more detailed identification and isolation of rare cells but this requires the development of additional fluorescent labelled antibodies against proteins specific to these cells. This can only be achieved by increasing our understanding of stem cell biology which is a major focus of stem cell research at the Institute of Human Genetics. Stem cells of all types are difficult to grow in vitro hence a better understanding of the signal transduction mechanisms which promote pluripotency in embryonic stem cells and contribute to interaction with the niche for adult stem cells are an essential part of this proposal. Multiparametric flow cytometry will be an important part of this investigation since may use it for parallel examination of multiple intracellular proteins with small numbers of cells.</gtr:technicalSummary><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>251512</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Inova Technology</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Testing of monoclonal antibodies</gtr:description><gtr:id>F01CB983-EB06-483B-B312-AE39AB582C81</gtr:id><gtr:piContribution>We are very active testing monoclonal antibodies for: 



Becton Dickinson

Miltenyi Biotec

Biolegend

Biostatus

Beta testing software for

Applied Cytometry Sheffield (Venturi one software)

Inivai Technologies, Victoria Australia (Gatelogic &amp;amp; Flow Logic) 



This allows us to do three things:



1 Acquire free antibodies from the companies allowing us to thoroughly test the suitability of the antibodies and fluorochromes at no cost to ourselves, in addition we have residual antibody left after this test that, if acceptable, we can use and or distribute to users.

2 Develop a symbiotic relationship with the companies whereby we often get free kits to run our internal user training (such as the Apoptosis course) at no cost in terms of reagents.

3 Because of the relationship we develop we often get asked to give our opinion on newly developed kits , and also , recently train users on instrumentation for Becton Dickinson

4 The ability to try and evaluate software inevitably leads to us acquiring free of charge the software in question and so adding to the users choice of free software available in the core facility.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>collaboration with Dr. Saretzki and Prof. von Zglinicki</gtr:description><gtr:id>355A7929-E42F-40E3-A823-43CBED742C63</gtr:id><gtr:impact>23818183
23722522
23280624
22311747
20073085
18203676
18055443
15790773
15536187
15511642</gtr:impact><gtr:partnerContribution>Our collaborators provide advice and assistance on telomerase, DNA damage and oxidative stress measurement assays.</gtr:partnerContribution><gtr:piContribution>We are interested in the role of telomerase, DNA damage and oxidative stress in ESC and iPSC as well as their derivatives for disease modelling studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BIO 2008 conference presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>64050519-9515-47D1-B357-E26C36236821</gtr:id><gtr:impact>30 minutes talk to a large audience (25,000 participants)

Radio conference followed the talk</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Using stem cells to understand our development and human disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A87E12FB-C61D-4449-86C4-2E2D13C6905D</gtr:id><gtr:impact>Talk

no actual impacts realised to date</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Flow cytometry training course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CFF53570-F040-44D6-B912-C6BDC5BB4B03</gtr:id><gtr:impact>Flow cytometry training course: Side population by flow cytometry This course is organised every year: number of participants between 20 and 30. Handbook produced

no actual impacts realised to date</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.guardian.co.uk/science/video/2010/mar/31/genetics-autism-zebra-finch</gtr:url><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Organiser of  the Newcastle RP Patient Information Day, 8th June 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4D0669AD-E8DB-4BD6-A057-7E317DA34A6D</gtr:id><gtr:impact>98 patients and their families attended the event which sparked a lot of questions, discussion and increased interest in application of stem cell therapies for retinal disease.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>https://campus.recap.ncl.ac.uk/Panopto/Pages/Viewer.aspx?id=d7b01a8a-3dfe-486e-b0ae-bc8d02b3e3f9</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>stem cell festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>12F8E4BD-FE67-46C5-A282-A437E30B6F60</gtr:id><gtr:impact>about 300 members of the public attended the event

we have been asked to participate every year</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>170000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Macular Disease Society PROJECT GRANT</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Macular Society</gtr:fundingOrg><gtr:id>F7D4B592-4F01-46FC-8B34-FB50BBBA00B9</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Confidence in Concept Scheme</gtr:department><gtr:description>Demonstrating proof of principle for generating a platform technology to direct differentiation of pluripotent stem cell using Sendai Viral vectors</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6C8B2580-04D9-4092-AF26-0D543432E72D</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>78000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Generation of disease models for Fanconi Anaemia using pluripotent stem cells</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>F1D4132A-3420-4F10-826E-B221CD9E0C8B</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>625000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/BBSRC Human iPS cell research project grant</gtr:description><gtr:end>2009-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A3FC1753-A58D-48E4-BF36-1796765D0A1D</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Stem cells for biological assays of novel drugs and predictive toxicology</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:fundingRef>STEMBANCC</gtr:fundingRef><gtr:id>035F7EB9-904A-47FF-8E98-6770E8545815</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>166000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigating haematopoietic development in Ligase IV and XLF patients using induced pluripotent stem cells</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>96D3707F-B31E-49E4-8C50-C16F0FA08B10</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1206610</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Translational Stem Cell Research Committee (TSCRC) Grant</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900879</gtr:fundingRef><gtr:id>35D9EFB9-F882-4954-A97A-AC4BD89D2C9F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>141849</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Equipment Grant</gtr:description><gtr:end>2009-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>46F44B67-B44B-4EFA-A95E-ABAA11537EF5</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Single Cell Genomics Unit</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M008886/1</gtr:fundingRef><gtr:id>929DA26A-D8C4-4A48-8D4F-A693A92F0BE2</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC CONSOLIDATOR FELLOWSHIP</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>614620</gtr:fundingRef><gtr:id>59336DD6-C80D-40FD-9E7A-D0E9FB6C9697</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RP Fighting Blindness project grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>RP Fighting Blindness</gtr:fundingOrg><gtr:fundingRef>GR584</gtr:fundingRef><gtr:id>70EE9697-DC7D-4D1E-89EE-EF155092C168</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>170000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fight for Sight project grant</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:fundingRef>1456/1457</gtr:fundingRef><gtr:id>D1FE1823-D31C-4B30-AB7A-1138BB1D31B5</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>166000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fight for Sight UK project grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>2A1295F9-C187-45D1-B1CD-B9EE86FC6986</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Chronic Granulomatous Disorder (CGD) Research Trust</gtr:department><gtr:description>Chronic Granulomatous Disease project grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>The Chronic Granulomatous Disorder Society</gtr:fundingOrg><gtr:id>17FE04FD-3349-4C95-A244-18149121FE75</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>146000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigation of the haematopoietic differentiation of human ES cells</gtr:description><gtr:end>2008-07-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>044F963C-0A40-43E1-9799-02017EABF04B</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2005-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC strategic tools and objectives scheme</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/I02333X/1</gtr:fundingRef><gtr:id>366CA7DE-FDBE-4D60-B18C-25767F4226D8</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Corneal epithelial stem cell therapy: enhancing safety and stability of cultured product</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>UCL Partners AHSC and AHSN</gtr:fundingOrg><gtr:id>92FCD634-8D64-404D-A0FA-DF6D3C2FA912</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fanconi Anaemia Fund project grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Fanconi Anemia Research Fund (FARF)</gtr:fundingOrg><gtr:id>498B346F-FA90-403C-8EF5-F87F881649D1</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The funding from this award has been used to establish the new multicolour state of the art flow cytometry system at the Institute of Genetic Medicine. This euqipment has provided a unique resource for Stem Cell groups in Newcastle and Durham University enabling research in areas of embryonic and somatic stem cell biology as well as developmental and cell biology projects across both campuses. The equipment is now part of the University wide flow cytometry core facility which is now self-funded through FEC based internal charging system.</gtr:description><gtr:exploitationPathways>Through collaborative links with Guava and BD Biosciences, we test a range of monoclonal antibodies and cell surface markers prior to their commercialisation using funds obtained via the KTP scheme. The equipment purchased via this equipment award is now part of the University wide flow cytometry core facility which is now self-funded through FEC based internal charging system.</gtr:exploitationPathways><gtr:id>01AD1AFC-8769-4BA4-88FC-2B49D9F9D842</gtr:id><gtr:sectors><gtr:sector>Leisure Activities, including Sports, Recreation and Tourism</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/83BE95A1-95AE-43A3-8805-9D4C19E785F2"><gtr:id>83BE95A1-95AE-43A3-8805-9D4C19E785F2</gtr:id><gtr:title>Potential for pharmacological manipulation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ff0b01918e51ffde4611885b3795d05"><gtr:id>8ff0b01918e51ffde4611885b3795d05</gtr:id><gtr:otherNames>Atkinson SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F63796BE-2148-4CFF-9766-1FFBDBC6E1ED"><gtr:id>F63796BE-2148-4CFF-9766-1FFBDBC6E1ED</gtr:id><gtr:title>Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/611bacfb261e714fa4a764f987ab2565"><gtr:id>611bacfb261e714fa4a764f987ab2565</gtr:id><gtr:otherNames>Ledran MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F5107D12-A049-4B7C-9100-72882FBCACC7"><gtr:id>F5107D12-A049-4B7C-9100-72882FBCACC7</gtr:id><gtr:title>Concise Review: Getting to the Core of Inherited Bone Marrow Failures.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ec93291033fb46554d744cbc2525eed"><gtr:id>1ec93291033fb46554d744cbc2525eed</gtr:id><gtr:otherNames>Adam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/179C8B57-E361-454D-846C-256F67F6C366"><gtr:id>179C8B57-E361-454D-846C-256F67F6C366</gtr:id><gtr:title>Engraftment's Holy Grail: is one signal enough?</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cb15855be4efb413999bcd624a98656e"><gtr:id>cb15855be4efb413999bcd624a98656e</gtr:id><gtr:otherNames>Lako M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9627B3E6-60E8-4BB5-A364-9AB24054D9DB"><gtr:id>9627B3E6-60E8-4BB5-A364-9AB24054D9DB</gtr:id><gtr:title>Putative role of hyaluronan and its related genes, HAS2 and RHAMM, in human early preimplantation embryogenesis and embryonic stem cell characterization.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/296450f418fdb5b05a0c398e2109e783"><gtr:id>296450f418fdb5b05a0c398e2109e783</gtr:id><gtr:otherNames>Choudhary M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9EE757A1-F886-4B10-B112-90E50EFB632C"><gtr:id>9EE757A1-F886-4B10-B112-90E50EFB632C</gtr:id><gtr:title>Epigenetic marking prepares the human HOXA cluster for activation during differentiation of pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ff0b01918e51ffde4611885b3795d05"><gtr:id>8ff0b01918e51ffde4611885b3795d05</gtr:id><gtr:otherNames>Atkinson SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4586E461-BBF0-4EC2-8EF1-7AD906C2E010"><gtr:id>4586E461-BBF0-4EC2-8EF1-7AD906C2E010</gtr:id><gtr:title>A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22E8F2EC-C4C5-415E-A762-9195DA2DAF2F"><gtr:id>22E8F2EC-C4C5-415E-A762-9195DA2DAF2F</gtr:id><gtr:title>SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f87b4d9f577d6cb8946b3b407d3a1d7b"><gtr:id>f87b4d9f577d6cb8946b3b407d3a1d7b</gtr:id><gtr:otherNames>Real PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/91608E40-3F81-45C4-BCDA-2A1119404AF7"><gtr:id>91608E40-3F81-45C4-BCDA-2A1119404AF7</gtr:id><gtr:title>The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc457f2ca8a244fd9a11f99914aec1bb"><gtr:id>cc457f2ca8a244fd9a11f99914aec1bb</gtr:id><gtr:otherNames>Zhu L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F59F5916-6A10-4855-A2F9-8D49C1A934B0"><gtr:id>F59F5916-6A10-4855-A2F9-8D49C1A934B0</gtr:id><gtr:title>G1 to S phase cell cycle transition in somatic and embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of anatomy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-8782</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30786D5D-D58F-4650-9140-51235159214D"><gtr:id>30786D5D-D58F-4650-9140-51235159214D</gtr:id><gtr:title>Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/311C75A1-78E4-43D4-80B0-821F06478ED3"><gtr:id>311C75A1-78E4-43D4-80B0-821F06478ED3</gtr:id><gtr:title>A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B9D95528-4F5E-4582-806E-3D348D964514"><gtr:id>B9D95528-4F5E-4582-806E-3D348D964514</gtr:id><gtr:title>JNK/SAPK Signaling Is Essential for Efficient Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14D3FF1C-DC25-4623-9ED5-EDBC1A271DDE"><gtr:id>14D3FF1C-DC25-4623-9ED5-EDBC1A271DDE</gtr:id><gtr:title>Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b936c0241c1c927f854b51d4ed55e8f9"><gtr:id>b936c0241c1c927f854b51d4ed55e8f9</gtr:id><gtr:otherNames>Mu?oz-L?pez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/34FD372D-EFF8-4C28-BAE2-4B3AEA2CC6C3"><gtr:id>34FD372D-EFF8-4C28-BAE2-4B3AEA2CC6C3</gtr:id><gtr:title>The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba0d5bcbc9af11be137705c5f84d8e19"><gtr:id>ba0d5bcbc9af11be137705c5f84d8e19</gtr:id><gtr:otherNames>Bigley V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/198EB4BB-1544-4114-BF34-EF216E472590"><gtr:id>198EB4BB-1544-4114-BF34-EF216E472590</gtr:id><gtr:title>Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).</gtr:title><gtr:parentPublicationTitle>Transgenic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a355c396ba09e2e636da788123a9b72d"><gtr:id>a355c396ba09e2e636da788123a9b72d</gtr:id><gtr:otherNames>Patek CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8819</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A67849B9-03DF-4C75-B94F-D5F81271B853"><gtr:id>A67849B9-03DF-4C75-B94F-D5F81271B853</gtr:id><gtr:title>Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ef36901ff24201f5a9ef60f60233e6a5"><gtr:id>ef36901ff24201f5a9ef60f60233e6a5</gtr:id><gtr:otherNames>Majlinda Lako (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>1476-5594</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5664249-20E1-48AF-BAFD-80A253F833E0"><gtr:id>A5664249-20E1-48AF-BAFD-80A253F833E0</gtr:id><gtr:title>Efficient stage-specific differentiation of human pluripotent stem cells toward retinal photoreceptor cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b1f9ae12417e7085ab2d1c329a907993"><gtr:id>b1f9ae12417e7085ab2d1c329a907993</gtr:id><gtr:otherNames>Mellough CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A3324D1-1A47-4173-B762-7D22640274FD"><gtr:id>3A3324D1-1A47-4173-B762-7D22640274FD</gtr:id><gtr:title>Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f665fcdbf37a51567b3080a9eaa06de2"><gtr:id>f665fcdbf37a51567b3080a9eaa06de2</gtr:id><gtr:otherNames>Haniffa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/701B9787-E99D-40E7-B40C-21CB932957FE"><gtr:id>701B9787-E99D-40E7-B40C-21CB932957FE</gtr:id><gtr:title>Multiplex High-Throughput Targeted Proteomic Assay To Identify Induced Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b8624cba5397e3f926bb9992f0b0cc59"><gtr:id>b8624cba5397e3f926bb9992f0b0cc59</gtr:id><gtr:otherNames>Baud A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D5460D17-4903-4A17-96BA-7565FAC2A3F3"><gtr:id>D5460D17-4903-4A17-96BA-7565FAC2A3F3</gtr:id><gtr:title>G1 to S transition and pluripotency: two sides of the same coin?</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cb15855be4efb413999bcd624a98656e"><gtr:id>cb15855be4efb413999bcd624a98656e</gtr:id><gtr:otherNames>Lako M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66C153DB-7DBB-421C-B75C-999710F4AD26"><gtr:id>66C153DB-7DBB-421C-B75C-999710F4AD26</gtr:id><gtr:title>An important role for adenine, cholera toxin, hydrocortisone and triiodothyronine in the proliferation, self-renewal and differentiation of limbal stem cells in&amp;nbsp;vitro.</gtr:title><gtr:parentPublicationTitle>Experimental eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6a0029150620f65feff65f8b10d27745"><gtr:id>6a0029150620f65feff65f8b10d27745</gtr:id><gtr:otherNames>Yu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-4835</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E41F8AE5-54F8-4C79-9BB7-74550EC68382"><gtr:id>E41F8AE5-54F8-4C79-9BB7-74550EC68382</gtr:id><gtr:title>Induced pluripotent stem cells : it looks simple but can looks deceive?</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cb15855be4efb413999bcd624a98656e"><gtr:id>cb15855be4efb413999bcd624a98656e</gtr:id><gtr:otherNames>Lako M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/854FE476-BC81-4671-84BB-43A0D41CC31A"><gtr:id>854FE476-BC81-4671-84BB-43A0D41CC31A</gtr:id><gtr:title>A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ef36901ff24201f5a9ef60f60233e6a5"><gtr:id>ef36901ff24201f5a9ef60f60233e6a5</gtr:id><gtr:otherNames>Majlinda Lako (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>1540-8140</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4A518AA-9410-436A-8363-0DCA60A5E86B"><gtr:id>D4A518AA-9410-436A-8363-0DCA60A5E86B</gtr:id><gtr:title>Large-scale transcriptional profiling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b8eba7c7d404762378d7575ce607376"><gtr:id>8b8eba7c7d404762378d7575ce607376</gtr:id><gtr:otherNames>Yung S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C0683FF8-4B64-4EAB-BE23-A48AD6574E02"><gtr:id>C0683FF8-4B64-4EAB-BE23-A48AD6574E02</gtr:id><gtr:title>The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B6D005AB-07B0-4269-8D7D-CDA2F59D8173"><gtr:id>B6D005AB-07B0-4269-8D7D-CDA2F59D8173</gtr:id><gtr:title>Circulating endothelial progenitor cells exhibit diurnal variation.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65d7e38d0d515d4d373b370ddec67f5c"><gtr:id>65d7e38d0d515d4d373b370ddec67f5c</gtr:id><gtr:otherNames>Thomas HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8FF0FD4C-C2A1-4C16-9971-B8AB2D096BB9"><gtr:id>8FF0FD4C-C2A1-4C16-9971-B8AB2D096BB9</gtr:id><gtr:title>Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d01a076dfa901adae664f235c784a02"><gtr:id>2d01a076dfa901adae664f235c784a02</gtr:id><gtr:otherNames>Saretzki G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/98874070-51CA-4FA6-BE3D-7AFEDA266419"><gtr:id>98874070-51CA-4FA6-BE3D-7AFEDA266419</gtr:id><gtr:title>Successful application of ex vivo expanded human autologous oral mucosal epithelium for the treatment of total bilateral limbal stem cell deficiency.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91ade9479bb633e247d863554bb61df3"><gtr:id>91ade9479bb633e247d863554bb61df3</gtr:id><gtr:otherNames>Kolli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF466D4C-EE17-43DA-B71A-AB7A74045F54"><gtr:id>FF466D4C-EE17-43DA-B71A-AB7A74045F54</gtr:id><gtr:title>Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DDF40FFA-4C56-4ECC-93FA-D0F4A0CE93BB"><gtr:id>DDF40FFA-4C56-4ECC-93FA-D0F4A0CE93BB</gtr:id><gtr:title>An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14998A68-964F-4DC7-ACFF-55BF031C2557"><gtr:id>14998A68-964F-4DC7-ACFF-55BF031C2557</gtr:id><gtr:title>An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7d6414b5561959e026a21adb7b56753"><gtr:id>f7d6414b5561959e026a21adb7b56753</gtr:id><gtr:otherNames>Jiang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1B4B43A5-E439-4703-B995-C28A927F2312"><gtr:id>1B4B43A5-E439-4703-B995-C28A927F2312</gtr:id><gtr:title>3D culture of human pluripotent stem cells in RGD-alginate hydrogel improves retinal tissue development.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/681fd0801fd1de7e49ac0cff1382adbc"><gtr:id>681fd0801fd1de7e49ac0cff1382adbc</gtr:id><gtr:otherNames>Hunt NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7094632E-975F-454B-97B9-3670E1EF9CF2"><gtr:id>7094632E-975F-454B-97B9-3670E1EF9CF2</gtr:id><gtr:title>Epigenetic landscaping during hESC differentiation to neural cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea73fc9b6c9490dc20f5e73048faf80c"><gtr:id>ea73fc9b6c9490dc20f5e73048faf80c</gtr:id><gtr:otherNames>Golebiewska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44AC7797-DCBE-4F97-9AA1-CF4F8182A708"><gtr:id>44AC7797-DCBE-4F97-9AA1-CF4F8182A708</gtr:id><gtr:title>Isolation of primordial germ cells from differentiating human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/636FCAE2-0E75-44F0-B26E-650F648CA729"><gtr:id>636FCAE2-0E75-44F0-B26E-650F648CA729</gtr:id><gtr:title>G1 to S transition and pluripotency: two sides of the same coin?</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ef36901ff24201f5a9ef60f60233e6a5"><gtr:id>ef36901ff24201f5a9ef60f60233e6a5</gtr:id><gtr:otherNames>Majlinda Lako (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>1551-4005</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D0D09CBA-3CC1-49B9-BB33-4F8A7B87CCC6"><gtr:id>D0D09CBA-3CC1-49B9-BB33-4F8A7B87CCC6</gtr:id><gtr:title>Silencing of the expression of pluripotent driven-reporter genes stably transfected into human pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/424da25bbe587e89ee3712f0b534778a"><gtr:id>424da25bbe587e89ee3712f0b534778a</gtr:id><gtr:otherNames>Stewart R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7F00852-7437-467B-9049-0DAEC4CDF062"><gtr:id>D7F00852-7437-467B-9049-0DAEC4CDF062</gtr:id><gtr:title>Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7d6414b5561959e026a21adb7b56753"><gtr:id>f7d6414b5561959e026a21adb7b56753</gtr:id><gtr:otherNames>Jiang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52223A76-7326-43DB-9E38-E2F01A64DD34"><gtr:id>52223A76-7326-43DB-9E38-E2F01A64DD34</gtr:id><gtr:title>Large-scale transcriptional profiling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8b8eba7c7d404762378d7575ce607376"><gtr:id>8b8eba7c7d404762378d7575ce607376</gtr:id><gtr:otherNames>Yung S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EBB760B1-CF59-488F-AFE0-1CF4D6998311"><gtr:id>EBB760B1-CF59-488F-AFE0-1CF4D6998311</gtr:id><gtr:title>Expression of GFP under the control of the RNA helicase VASA permits fluorescence-activated cell sorting isolation of human primordial germ cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B270A5E-891E-422B-9537-182455B70C1A"><gtr:id>7B270A5E-891E-422B-9537-182455B70C1A</gtr:id><gtr:title>Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/663D2745-5B88-4D0E-A9A2-8885034238B8"><gtr:id>663D2745-5B88-4D0E-A9A2-8885034238B8</gtr:id><gtr:title>Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/90beae265cc66a609b94676c64beab85"><gtr:id>90beae265cc66a609b94676c64beab85</gtr:id><gtr:otherNames>Yung SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76CBAAA7-1AFE-4C9D-8E36-5D644B62DF31"><gtr:id>76CBAAA7-1AFE-4C9D-8E36-5D644B62DF31</gtr:id><gtr:title>Opposing putative roles for canonical and noncanonical NF?B signaling on the survival, proliferation, and differentiation potential of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/851a472230d2cd69a9cab22daa89e275"><gtr:id>851a472230d2cd69a9cab22daa89e275</gtr:id><gtr:otherNames>Yang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F471D0F-B658-41FB-BE99-1243B5713E76"><gtr:id>5F471D0F-B658-41FB-BE99-1243B5713E76</gtr:id><gtr:title>Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7d6414b5561959e026a21adb7b56753"><gtr:id>f7d6414b5561959e026a21adb7b56753</gtr:id><gtr:otherNames>Jiang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/346A02AB-14FC-42A2-A969-DDDCD657AF18"><gtr:id>346A02AB-14FC-42A2-A969-DDDCD657AF18</gtr:id><gtr:title>Opposing putative roles for canonical and noncanonical NF?B signaling on the survival, proliferation, and differentiation potential of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/851a472230d2cd69a9cab22daa89e275"><gtr:id>851a472230d2cd69a9cab22daa89e275</gtr:id><gtr:otherNames>Yang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/72C44E30-3EE5-47DB-A0B3-9981353C3234"><gtr:id>72C44E30-3EE5-47DB-A0B3-9981353C3234</gtr:id><gtr:title>A putative role for the immunoproteasome in the maintenance of pluripotency in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ff0b01918e51ffde4611885b3795d05"><gtr:id>8ff0b01918e51ffde4611885b3795d05</gtr:id><gtr:otherNames>Atkinson SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B7F8EE47-35E7-4E07-8A87-2C097E2032BF"><gtr:id>B7F8EE47-35E7-4E07-8A87-2C097E2032BF</gtr:id><gtr:title>Brief report: a human induced pluripotent stem cell model of cernunnos deficiency reveals an important role for XLF in the survival of the primitive hematopoietic progenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A978A6CF-4D77-40CE-9723-518AEDC101CB"><gtr:id>A978A6CF-4D77-40CE-9723-518AEDC101CB</gtr:id><gtr:title>Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Kruppel-like zinc-finger protein family and WT1 protein isoforms.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1931b568cd4fa918bd75b59c55289ed3"><gtr:id>1931b568cd4fa918bd75b59c55289ed3</gtr:id><gtr:otherNames>Florio F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54C2F1A0-F6B6-47E8-90D9-2C76EBA13CB5"><gtr:id>54C2F1A0-F6B6-47E8-90D9-2C76EBA13CB5</gtr:id><gtr:title>Expression of GFP under the control of the RNA helicase VASA permits fluorescence-activated cell sorting isolation of human primordial germ cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31c74aba4bcf852a6649ec5235a6b1ef"><gtr:id>31c74aba4bcf852a6649ec5235a6b1ef</gtr:id><gtr:otherNames>Tilgner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6993BA62-C81F-4BC7-8E7E-422F5D5D3E6C"><gtr:id>6993BA62-C81F-4BC7-8E7E-422F5D5D3E6C</gtr:id><gtr:title>13 years of cultured limbal epithelial cell therapy: a review of the outcomes.</gtr:title><gtr:parentPublicationTitle>Journal of cellular biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/06ec9f3e4ff8da4fa711f9c1bb44eaf9"><gtr:id>06ec9f3e4ff8da4fa711f9c1bb44eaf9</gtr:id><gtr:otherNames>Baylis O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0730-2312</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3B13E988-E92F-4F67-A296-9D27DA844693"><gtr:id>3B13E988-E92F-4F67-A296-9D27DA844693</gtr:id><gtr:title>Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65d7e38d0d515d4d373b370ddec67f5c"><gtr:id>65d7e38d0d515d4d373b370ddec67f5c</gtr:id><gtr:otherNames>Thomas HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16368466-F5C4-4F10-9CD8-E951D0743A89"><gtr:id>16368466-F5C4-4F10-9CD8-E951D0743A89</gtr:id><gtr:title>A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0d10ae0b5fee7f7d7a790e1b961f1e4"><gtr:id>f0d10ae0b5fee7f7d7a790e1b961f1e4</gtr:id><gtr:otherNames>Zhang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/48985B29-3B69-4F69-9C2D-8060AA3D25CD"><gtr:id>48985B29-3B69-4F69-9C2D-8060AA3D25CD</gtr:id><gtr:title>The limbal epithelium of the eye--a review of limbal stem cell biology, disease and treatment.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/556fd8969cc458a99fa1955112bbfcd8"><gtr:id>556fd8969cc458a99fa1955112bbfcd8</gtr:id><gtr:otherNames>Osei-Bempong C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F28DF75C-A15D-488F-A128-099462A4B514"><gtr:id>F28DF75C-A15D-488F-A128-099462A4B514</gtr:id><gtr:title>Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94A92F80-3648-461D-A9F3-C2195368D4A8"><gtr:id>94A92F80-3648-461D-A9F3-C2195368D4A8</gtr:id><gtr:title>Brief Report: Inhibition of miR-145 Enhances Reprogramming of Human Dermal Fibroblasts to Induced Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6a7d043f9ead19fb2476e7ac52aeab9e"><gtr:id>6a7d043f9ead19fb2476e7ac52aeab9e</gtr:id><gtr:otherNames>Barta T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/391CD730-D5FE-4E78-AAF1-8D4EF8CE1812"><gtr:id>391CD730-D5FE-4E78-AAF1-8D4EF8CE1812</gtr:id><gtr:title>Tissue engineering using pluripotent stem cells: multidisciplinary approaches to accelerate bench-to-bedside transition.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/681fd0801fd1de7e49ac0cff1382adbc"><gtr:id>681fd0801fd1de7e49ac0cff1382adbc</gtr:id><gtr:otherNames>Hunt NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/24FF2463-E914-43BC-A9B6-F25FECD00A4A"><gtr:id>24FF2463-E914-43BC-A9B6-F25FECD00A4A</gtr:id><gtr:title>A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/851a472230d2cd69a9cab22daa89e275"><gtr:id>851a472230d2cd69a9cab22daa89e275</gtr:id><gtr:otherNames>Yang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0EF8FC8D-091C-440B-856A-DF6729CB5AC2"><gtr:id>0EF8FC8D-091C-440B-856A-DF6729CB5AC2</gtr:id><gtr:title>Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/711d7c4345cd767e79003f4e4f4b46d2"><gtr:id>711d7c4345cd767e79003f4e4f4b46d2</gtr:id><gtr:otherNames>Allegrucci C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/074D7B79-FEDE-40F9-BE22-CD3E67B5B1BC"><gtr:id>074D7B79-FEDE-40F9-BE22-CD3E67B5B1BC</gtr:id><gtr:title>Generation of Human Induced Pluripotent Stem Cells Using RNA-Based Sendai Virus System and Pluripotency Validation of the Resulting Cell Population.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b3f34322e8a12bb45e58953b383666c4"><gtr:id>b3f34322e8a12bb45e58953b383666c4</gtr:id><gtr:otherNames>Chichagova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/88251BD2-C12A-4F15-A8CC-1FCDD715BB30"><gtr:id>88251BD2-C12A-4F15-A8CC-1FCDD715BB30</gtr:id><gtr:title>CDK1 plays an important role in the maintenance of pluripotency and genomic stability in human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4725828763ea18f9bb08c64817c6472f"><gtr:id>4725828763ea18f9bb08c64817c6472f</gtr:id><gtr:otherNames>Neganova I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ECFD89C6-3627-401E-94DF-182E25DA2D6F"><gtr:id>ECFD89C6-3627-401E-94DF-182E25DA2D6F</gtr:id><gtr:title>Circulating endothelial progenitor cell numbers are not associated with donor organ age or allograft vasculopathy in cardiac transplant recipients.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65d7e38d0d515d4d373b370ddec67f5c"><gtr:id>65d7e38d0d515d4d373b370ddec67f5c</gtr:id><gtr:otherNames>Thomas HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E012841/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>